Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s stock price was up 1.4% on Thursday . The stock traded as high as $1.8550 and last traded at $1.8550. Approximately 731 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 5,454 shares. The stock had previously closed at $1.83.
Mayne Pharma Group Stock Performance
The firm’s 50 day moving average is $2.07 and its 200-day moving average is $2.82.
Mayne Pharma Group Company Profile
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
Featured Articles
- Five stocks we like better than Mayne Pharma Group
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
